These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7165419)

  • 21. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
    Warltier DC; Meils CM; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):296-302. PubMed ID: 7248040
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
    Wambach G; Breuer G; Kaufmann W
    Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552).
    Basu DK; Brahmankar DM
    Mater Med Pol; 1985; 17(2):103-6. PubMed ID: 4079466
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypotensive effects of dihydropyridine derivatives.
    Kamei C; Kurokawa K; Tasaka K
    Arzneimittelforschung; 1985; 35(9):1377-80. PubMed ID: 2935160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myocardial effects of the calcium antagonists nifedipine, nisoldipine and isradipine in coronary heart disease].
    Mauser M; Voelker W; Ickrath O; Kühlkamp V; Karsch KR
    Dtsch Med Wochenschr; 1990 May; 115(19):723-9. PubMed ID: 2140095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effects of m-nisoldipine and nisoldipine on conscious renal hypertensive rats and dogs.
    Liu WH; Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1992 Jan; 13(1):31-5. PubMed ID: 1605031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of three calcium entry blockers in conscious dogs.
    Eigenmann R; Gerold M
    Arzneimittelforschung; 1987 Sep; 37(9):1020-5. PubMed ID: 3435596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Kawahara J; Jinno Y; Endo M; Izumi H; Takeuchi A; Izawa T
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):814-9. PubMed ID: 9234664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of nisoldipine, diltiazem, nifedipine, and verapamil on hemodynamic parameters and red blood cells-platelet interactions in patients with arterial hypertension.
    Belousov Y; Kushnaryov V
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S32-5. PubMed ID: 1725540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of nifedipine on conscious renal-hypertensive dogs.
    Hiwatari M; Satoh K; Taira N
    Arzneimittelforschung; 1979; 29(2):256-60. PubMed ID: 582138
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of the calcium antagonist nisoldipine on electrophysiologic parameters in the human].
    Klein HH; Nordbeck H; Kreuzer H
    Z Kardiol; 1983 Mar; 72(3):180-2. PubMed ID: 6858297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of the new vasodilator drug Bay k 5552 in man.
    Vogt A; Neuhaus KL; Kreuzer H
    Arzneimittelforschung; 1980; 30(12):2162-4. PubMed ID: 7194078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors involved in the antihypertensive action of calcium antagonists.
    Garthoff B; Kazda S; Knorr A; Thomas G
    Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of benidipine hydrochloride on atrioventricular conduction time and postural reflex in gallamine-immobilized cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1698-701. PubMed ID: 3219143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Castellano M; Alicandri CL; Corea L; Fariello R; Beschi M; Romanelli G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs.
    Crottogini AJ; Depaoli JR; Barra JG; Fischer EC; Rodríguez Chatruc M; Pichel RH; de la Fuente L
    Am Heart J; 1985 Oct; 110(4):753-60. PubMed ID: 4050646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.